Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Shares | 101.590 | 101.590 | 0.000 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 17.474 | 19.279 |
| Price to Book | 2.704 | 3.740 |
| Price to Sales | 1.943 | 2.180 |
| Price to Cash Flow | 15.472 | 14.521 |
| Dividend Yield | 0.538 | 1.489 |
| 5 Years Earnings Growth | 12.774 | 9.738 |
Number of long holdings: 34
Number of short holdings: 1
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| UCB | BE0003739530 | 8.39 | 222.50 | -6.36% | |
| Swedish Orphan Biovitrum | SE0000872095 | 6.99 | 327.20 | -1.33% | |
| Argen-X | NL0010832176 | 6.00 | 705.60 | +0.46% | |
| Zealand Pharma | DK0060257814 | 5.16 | 512.60 | +8.86% | |
| Fresenius SE | DE0005785604 | 4.97 | 50.020 | -0.68% | |
| H Lundbeck B | DK0061804770 | 3.76 | 47.18 | -0.08% | |
| Merus | NL0011606264 | 3.62 | 94.86 | -0.21% | |
| Uniphar | IE00BJ5FQX74 | 3.55 | 3.83 | 0.00% | |
| Innovent Biologics | KYG4818G1010 | 3.47 | 87.00 | +7.81% | |
| Ascendis Pharma AS | US04351P1012 | 3.21 | 201.60 | -1.04% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Global Technology Fund I E | 10.79B | 42.16 | 41.32 | 22.94 | ||
| Global Technology Fund RE | 10.79B | 41.63 | 40.61 | 22.40 | ||
| Global Technology FunD E | 10.79B | 17.39 | 29.43 | 19.08 | ||
| IE00BZ4D7648 | 10.79B | 2.04 | 16.56 | - | ||
| IE00BZ4D7085 | 10.79B | 2.23 | 17.11 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review